- Paper Report
- Open Access
Pathogenic role of anti-myeloperoxidase ANCA
- Martin Aringer1
© Biomed Central Ltd 2002
- Received: 15 November 2002
- Accepted: 27 November 2002
- Published: 27 November 2002
- microscopic panarteritis
- pauci-immune glomerulonephritis
- perinuclear ANCA
Antineutrophil cytoplasmatic antibodies (ANCA) are present in many patients with systemic vasculitides, with myeloperoxidase (MPO) and proteinase-3 (PR-3) being the main autoantigens in (microscopic) panarteritis nodosa (PAN) and Wegener's granulomatosis (WG), respectively. ANCA are associated with disease activity, but their role in disease pathogenesis has remained obscure.
Rag2-/- mice lack functional B and T cells. Splenocytes of MPO-/- mice immunized with purified MPO were transferred to Rag2-/- recipients and developed MPO-ANCA. 80% of Rag2-/- mice receiving 1x108 or 5x107 splenocytes from MPO-immunized mice developed a pauci-immune glomerulonephritis with increased serum creatinine and blood urea nitrogen (BUN), proteinuria, an active urinary sediment, and fibrinoid necrosis and crescents in their glomeruli. One third of the animals developed hemorrhagic pulmonary capillaritis, 2/16 developed necrotizing arteritis, and in one animal necrotizing granulomatous inflammation was found in the spleen. Mice receiving 1x108 splenocytes from BSA-immunized or non-immunized animals developed mild glomerular lesions with moderate glomerular hypercellularity. Purified IgG derived from mice immunized with MPO, but not from control animals immunized with BSA, induced pauci-immune crescentic glomerulonephritis both in Rag2-/- and in wildtype B6 mice. 2/6 wildtype B6 mice developed capillaritis; 3/6 had skin ulceration with necrotizing arteritis proven in one case.
Rag2-/- mice, B6 mice, immunization of MPO-/- mice with MPO or BSA, splenocytes transfer, IgG transfer, ELISA, histology, immunofluorescence, electron microscopy
The article is accompanied by a commentary (D'Agati V: Antineutrophil cytoplasmic antibody and vasculitis: much more than a disease marker. J Clin Invest 2002, 110: 919-921).